Oscar Millet is an expert in Biochemistry at Instituto de Salud Carlos III (Spain). Oscar Millet has authored 191 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 927 (community average: 125). How the SLR is computed.

LeadR Profile

927 ScienceLeadR Reputation 927
Network Map

Biochemistry

Subspecialties: Gastroenterology - Hepatology - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1998 - 2026

Source: PubMed

CIC bioGUNE

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 191

Citations

Citations: 7 944 1st author: 11 Last author: 57 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Searching for Metabolic Markers for Hypertension in Human Urine.
PMID 42796632 — hypertension, comorbidity, cardiovascular diseases, phenylalanine, biomarkers, metabolomics, acetone, sarcosine
Molecules20260
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.
PMID 42498741 — serum, fibrosis, elasticity imaging techniques, non-alcoholic fatty liver disease, liver, biomarkers
Nat Med Top journal20268
The case for primary prevention of obesity in the era of GLP-1 therapies.
PMID 42403918 — glucagon-like peptide 1, drug therapy, obesity, primary prevention, therapeutics
Lancet Reg Health Eur20261
NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals.
PMID 42310722 — cytokines, endometriosis, body mass index, serum, amino acids, lipoproteins, biomarkers, healthy volunteers
BMC Med20260
Rational Design of Small-Molecule Stabilizers of Human Fumarylacetoacetate Hydrolase for the Treatment of Tyrosinemia Type I.
PMID 42117404 — hydrolases, tyrosinemias, liver, therapeutics, small molecules
J Med Chem20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Completed 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 2

LeadR Networks

Main global connection map